Furthermore, common molecular alterations include TP53 mutations, downregulation of PTEN, and mutations in telomerase-related genes, such as TERC and TERT, all of which are shared between IPF and non-small-cell lung cancer (NSCLC) [7]. This evidence concerns the gene PTEN and non-small cell lung carcinoma.